Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Biographical Sketch
Beth Leventhal Fromkin, MD was born and raised in Brooklyn, NY. She has been with Cleveland Clinic Florida in the Department of Nephrology since 2001.
She is a graduate of Stuyvesant High School and Princeton University. She attended medical school at Albert Einstein College of Medicine of Yeshiva University in Bronx, NY. She completed her internal medicine Residency at Yale-New Haven Hospital in New Haven, CT and completed her fellowship in Nephrology at NY Presbyterian Hospital Cornell Medical Center in New York, NY. After completing her nephrology fellowship, she then completed a second fellowship in Hypertension at NY Presbyterian Hospital Cornell Medical Center in New York, NY. She is board certified in Nephrology by the American Board of Internal Medicine and is also board certified in Hypertension by the American Society of Hypertension. She is currently one of only 46 board certified hypertension specialists in the State of Florida.
Dr. Beth Fromkin specializes in all aspects of inpatient and outpatient kidney disease and has expertise in renal transplant medicine. She treats complex and secondary causes of hypertension. She performs hemodialysis, peritoneal dialysis, CVV-H, and CVV-HD. She performs kidney biopsies and treats vasculitis and nephritis. She is an active teacher in the Department's fully accredited Nephrology fellowship program. She is active in the Princeton University Alumni Association.
Specialty Interests
chronic kidney disease, dialysis, dialysis chronic kidney disease, dialysis and kidney biopsy, end stage renal disease, general nephrology, glomerulonephritis, hypertension, predialysis care, renal biopsies, renal diseases, renal transplantation medicine
Industry Relationships
Cleveland Clinic physicians and scientists report if they
have any collaborations with the pharmaceutical or medical
device industries as part of the Cleveland Clinic’s
procedures. The Cleveland Clinic publicly discloses
payments to its physicians and scientists for speaking and
consulting of $5,000 or more per year, and any equity,
royalties, and fiduciary relationships in companies with
which they collaborate. In publicly disclosing this
information, the Cleveland Clinic tries to provide
information as accurately as possible about its doctors’
connections with industry and those of their immediate
family members. As of 6/15/2010,
Dr. Fromkin has reported no financial relationship with
industry that is applicable to this listing. Patients
should feel free to contact their doctor about
relationships with industry and how the relationships are
overseen by the Cleveland Clinic. To learn more about
the Cleveland Clinic’s policies on collaborations with
industry and innovation management, go to our
Integrity in Innovation page.
